Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob T Li

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
Biomedicines|July 29, 2023
Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-AnalysisJoe Q Wei, Alexander Yuile, Malinda Itchins, et al.
Oxford Medical Case Reports|May 20, 2015
Dramatic response to selective internal radiation therapy for unresectable hepatocellular carcinomaWoo Daniel Park, Bob T Li, Richard Maher, et al.
Cancer Research Communications|April 3, 2025
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid TumorsDazhi Liu, Justin Jee, Alexander Drilon, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2015
HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinibBob T Li, Adrian Lee, Sandra O'Toole, et al.
Annals of Translational Medicine|December 30, 2017
Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancersBob T Li, Dennis Stephens, Jamie E Chaft, et al.
Journal of Clinical Medicine|August 4, 2015
Malignant Cardiac Tamponade from Non-Small Cell Lung Cancer: Case Series from the Era of Molecular Targeted TherapyBob T Li, Antonia Pearson, Nick Pavlakis, et al.
Cancer Chemotherapy and Pharmacology|April 1, 2018
Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignanciesBoaz Mendzelevski, Georg Ferber, Filip Janku, et al.
The Cochrane Database of Systematic Reviews|June 28, 2017
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancerDavid Lok Hang Chan, Eva Segelov, Rachel Sh Wong, et al.
Oxford Medical Case Reports|May 20, 2015
Localized malignant pleural mesothelioma with renal metastasisSarah Jane Zardawi, Bob T Li, Marjorie G Zauderer, et al.
Advances in Radiation Oncology|December 6, 2017
Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancerBenjamin H Lok, Jennifer Ma, Amanda Foster, et al.
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Biomedicines|July 29, 2023
Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-AnalysisJoe Q Wei, Alexander Yuile, Malinda Itchins, et al.
Oxford Medical Case Reports|May 20, 2015
Dramatic response to selective internal radiation therapy for unresectable hepatocellular carcinomaWoo Daniel Park, Bob T Li, Richard Maher, et al.
Cancer Research Communications|April 3, 2025
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid TumorsDazhi Liu, Justin Jee, Alexander Drilon, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2015
HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinibBob T Li, Adrian Lee, Sandra O'Toole, et al.
Annals of Translational Medicine|December 30, 2017
Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancersBob T Li, Dennis Stephens, Jamie E Chaft, et al.
Journal of Clinical Medicine|August 4, 2015
Malignant Cardiac Tamponade from Non-Small Cell Lung Cancer: Case Series from the Era of Molecular Targeted TherapyBob T Li, Antonia Pearson, Nick Pavlakis, et al.
Cancer Chemotherapy and Pharmacology|April 1, 2018
Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignanciesBoaz Mendzelevski, Georg Ferber, Filip Janku, et al.
The Cochrane Database of Systematic Reviews|June 28, 2017
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancerDavid Lok Hang Chan, Eva Segelov, Rachel Sh Wong, et al.
Oxford Medical Case Reports|May 20, 2015
Localized malignant pleural mesothelioma with renal metastasisSarah Jane Zardawi, Bob T Li, Marjorie G Zauderer, et al.
Advances in Radiation Oncology|December 6, 2017
Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancerBenjamin H Lok, Jennifer Ma, Amanda Foster, et al.
Pageof 14